Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.

Novo's earnings results Wednesday differ from Eli Lilly's, whose stock slid on slower-than-expected sales of weight loss ...

Xavier Becerra, the outgoing Health and Human ... Among the medications are popular weight loss treatments like Wegovy and Ozempic. "It will be left to the next administration to do the ...

Xavier Becerra, the outgoing Health and Human Services secretary ... Among the medications are popular weight loss treatments like Wegovy and Ozempic. "It will be left to the next administration to do ...

Popular weight-loss drugs Ozempic and Wegovy are ... according to U.S. Health and Human Services Secretary Xavier Becerra. The anticipated savings are expected to alleviate financial burdens ...